Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis-Reference-Cited by-同舟云学术

Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis

Published:2008-11 Issue:5 Volume:156 Page:855-863.e2
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Goto Shinya,Bhatt Deepak L.,Röther Joachim,Alberts Mark,Hill Michael D.,Ikeda Yasuo,Uchiyama Shinichiro,D'Agostino Ralph,Ohman E. Magnus,Liau Chiau-Suong,Hirsch Alan T.,Mas Jean-Louis,Wilson Peter W.F.,Corbalán Ramón,Aichner Franz,Steg P. Gabriel

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference37 articles.

1. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study;Benjamin;Circulation,1998

2. Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study;Wachtell;J Am Coll Cardiol,2005

3. Coronary ischemic events after first atrial fibrillation: risk and survival;Miyasaka;Am J Med,2007

4. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications;Feinberg;Arch Intern Med,1995

5. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study;Heeringa;Eur Heart J,2006

Cited by 237 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases;European Heart Journal;2024-08-30

2. Patency and Survival in Patients Undergoing Revascularization for Peripheral Arterial Disease;Sağlık Bilimlerinde Değer;2024-05-22

3. Editor's Choice -- European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication;European Journal of Vascular and Endovascular Surgery;2024-01

4. Direct Oral Anticoagulants use in Patients with Stable Coronary Artery Disease, Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention;Current Pharmaceutical Design;2023-10

5. New-onset atrial fibrillation and chronic coronary syndrome in the CLARIFY registry;European Heart Journal;2023-08-27